Top Analyst Upgrades and Downgrades: Comerica, Cree, Ericsson, Kroger, Regado Biosciences, Sequenom and More

These are this Thursday’s top analyst upgrades, downgrades and initiations from Wall Street firms.

Athlon Energy Inc. (NYSE: ATHL) was raised to Buy from Neutral at UBS. RBC Capital Markets has a Outperform rating but raised its target to $56 from $48 in the call.

Comerica Inc. (NYSE: CMA) was downgraded to Neutral from Buy at Citigroup.

Cree Inc. (NASDAQ: CREE) was raised to Outperform from Perform with a $59 price target (versus a $50.31 close) at Oppenheimer.

ALSO READ: Four Solid Dividends Yielding 9.5% or Higher

Cummins Inc. (NYSE: CMI) was reiterated as Buy with a target price of $170 at Argus.

Ericsson (NASDAQ: ERIC) was started with a Hold rating at Jefferies.

KeyCorp (NYSE: KEY) assumed with a Neutral at Citigroup.

Kroger Co. (NYSE: KR) was reiterated as Buy and the firm raised its target to $55 from $49 after the $49 price came up and based on better e-commerce sales expectations at Argus.

Lazard Ltd. (NYSE: LAZ) was downgraded to Outperform from Buy and the target price is $58 (versus a $51.43 close) at Raymond James.

Regado Biosciences Inc. (NASDAQ: RGDO) was downgraded to Underperform from Outperform at Wedbush, but that price target was slashed to $2 from $10 (versus a $6.76 close and $3.10 early indications). Whoops!

Regions Financial Corp. (NYSE: RF) was started with a Neutral rating at Citigroup.

ResMed Inc. (NYSE: RMD) was downgraded to Hold from Buy and the price target is now $52 (versus a $50.50 close) at Deutsche Bank.

Sequenom Inc. (NASDAQ: SQNM) was started as Buy with a $5 price target (versus a $3.97 close) at Jefferies.

Sterling Bancorp (NYSE: STL) was started with an Outperform rating and $14 price target at Raymond James.

SunTrust Banks Inc. (NYSE: STI) was started with a Neutral rating at Citigroup.

ALSO READ: Merrill Lynch’s Catalyst-Driven Third-Quarter Stock Picks

In case you missed Wednesday’s analyst upgrades and downgrades, these included Alcatel-Lucent, FireEye, JDS Uniphase, SolarCity, SunPower, SunEdison and over a dozen more.

Tuesday’s upgrades and downgrades included Amicus Therapeutics, comScore, Expedia, Juniper Networks, Netflix, MannKind, Xerox and a dozen or so more. Also, here are nine analyst stock picks under $10 with massive upside potential.